Skip to content
Screener

Kodiak Sciences Inc KOD Operating Income

Operating Income at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$1.29B+19.8%
EyePoint, Inc. logo
EyePoint, Inc.EYPT
-$97.38M-56.5%
KLR
Kalaris TherapeuticsKLRS
-$11.83M-14.3%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
-$73.62M-37.3%
HRO
HarrowHROW
-$22.08M-96.6%
PVL
Palvella TherapeuticsPVLA
-$14.86M-88.7%

Other financials

Income statement

See full
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.84B+556%
Enterprise value$2.73B+592%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211951
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Research and development$48,547$43,644
General and administrative11,23015,429
Total operating expenses59,77759,073
Loss from operations(59,777)(59,073)
Interest income1,6411,602
Other income (expense), net(22)10
Net loss and comprehensive loss$(58,158)$(57,461)
Net loss per share, basic and diluted$(0.94)$(1.09)

Item 1. Financial Statements (Unaudited).

FAQ

What is Kodiak Sciences Inc's operating income?
Kodiak Sciences Inc (KOD) reported operating income of -$59.78M in Q1 2026.
How has Kodiak Sciences Inc's operating income changed year-over-year?
Kodiak Sciences Inc's operating income decreased by 1.2% year-over-year, from -$59.07M to -$59.78M.
What is the long-term trend for Kodiak Sciences Inc's operating income?
Over 4 years (2021 to 2025), Kodiak Sciences Inc's operating income has grown at a -3.2% compound annual growth rate (CAGR), from -$267.05M to -$234.39M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Ask your AI about Kodiak Sciences Inc's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude